Advances in prostate cancer chemotherapy: A new era begins

Keyphrases

• Prostate Cancer 100%
• Cancer Chemotherapy 100%
• Androgen Receptor 66%
• New Standards 33%
• Malignancy 33%
• Cancer Mortality 33%
• Metastasis 33%
• Androgen-independent 33%
• Multiple Mechanisms 33%
• Signal Transduction Pathway 33%
• Prostate Cancer Patients 33%
• Remission 33%
• Survival Benefit 33%
• Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 33%
• First-line Therapy 33%
• Standard of Care 33%
• Bisphosphonates 33%
• New Targeted Therapy 33%
• Androgen Deprivation Therapy 33%
• Androgen Independence 33%
• Hormone-sensitive Prostate Cancer 33%
• Radioisotopes 33%
• Androgen Signaling 33%
• Male Cancer 33%
• Independent States 33%
• Zoledronic Acid 33%
• Docetaxel Chemotherapy 33%

Medicine and Dentistry

• Prostate Cancer 100%
• Cancer Chemotherapy 100%
• Androgen 80%
• Androgen Receptor 40%
• Disease 20%
• Cancer 20%
• Metastatic Carcinoma 20%
• Targeted Therapy 20%
• Chemotherapy 20%
• Signal Transduction Pathway 20%
• Cancer Mortality 20%
• Radioisotope 20%
• Docetaxel 20%
• Bisphosphonate 20%
• Zoledronic Acid 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Cancer Chemotherapy 100%
• Androgen 80%
• Androgen Receptor 40%
• Disease 20%
• Chemotherapy 20%
• Remission 20%
• Docetaxel 20%
• Cancer Mortality 20%
• Radioisotope 20%
• Bisphosphonic Acid Derivative 20%
• Zoledronic Acid 20%